最近搜索:細(xì)胞培養(yǎng) 微生物學(xué) 分子生物 生物化學(xué)
    首頁(yè)>>免疫學(xué)>>一抗>>磷酸化絲氨酸/蘇氨酸蛋白激酶抗體
    磷酸化絲氨酸/蘇氨酸蛋白激酶抗體
    • 產(chǎn)品貨號(hào):
      BN40889R
    • 中文名稱:
      磷酸化絲氨酸/蘇氨酸蛋白激酶抗體
    • 英文名稱:
      Rabbit anti-Phospho-LKB1 (Thr189) Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號(hào)

      產(chǎn)品規(guī)格

      售價(jià)

      備注

    • BN40889R-100ul

      100ul

      ¥2470.00

      交叉反應(yīng):Human(predicted:Mouse,Rat,Pig,Cow) 推薦應(yīng)用:WB,ELISA

    產(chǎn)品描述

    英文名稱Phospho-LKB1 (Thr189)
    中文名稱磷酸化絲氨酸/蘇氨酸蛋白激酶抗體
    別    名STK11(phospho T189); LKB1(phospho Thr189); LKB1 (phospho T189); p-LKB1 (phospho T189); p-LKB1(phospho Thr189); p-LKB1(T189); LKB1; PJS; Renal carcinoma antigen NY-REN-19; Serine/Threonine Kinase 11; Serine/threonine protein kinase 11; Serine/threonine protein kinase LKB1; Serine/threonine-protein kinase 11; Serine/threonine-protein kinase LKB1; Stk11; STK11_HUMAN; hLKB1; Liver kinase B1; LKB 1; NY REN 19 antigen; Peutz Jeghers syndrome; PJS; Polarization related protein LKB1; Serine/threonine protein kinase STK11; Serine/threonine-protein kinase XEEK1; STK 11.  
    產(chǎn)品類型磷酸化抗體 
    研究領(lǐng)域腫瘤  免疫學(xué)  神經(jīng)生物學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  細(xì)胞凋亡  轉(zhuǎn)錄調(diào)節(jié)因子  激酶和磷酸酶  
    抗體來(lái)源Rabbit
    克隆類型Polyclonal
    交叉反應(yīng)Human,  (predicted: Mouse, Rat, Pig, Cow, )
    產(chǎn)品應(yīng)用WB=1:500-2000 ELISA=1:5000-10000 
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量48kDa
    細(xì)胞定位細(xì)胞核 細(xì)胞漿 細(xì)胞膜 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthesised phosphopeptide derived from human LKB1 around the phosphorylation site of Thr189:G(p-T)LK 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲(chǔ) 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產(chǎn)品介紹This gene, which encodes a member of the serine/threonine kinase family, regulates cell polarity and functions as a tumor suppressor. Mutations in this gene have been associated with Peutz-Jeghers syndrome, an autosomal dominant disorder characterized by the growth of polyps in the gastrointestinal tract, pigmented macules on the skin and mouth, and other neoplasms. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008].

    Function:
    Tumor suppressor serine/threonine-protein kinase that controls the activity of AMP-activated protein kinase (AMPK) family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. Acts by phosphorylating the T-loop of AMPK family proteins, leading to promote their activity: phosphorylates PRKAA1, PRKAA2, BRSK1, BRSK2, MARK1, MARK2, MARK3, MARK4, NUAK1, NUAK2, SIK1, SIK2, SIK3 and SNRK but not MELK. Also phosphorylates non-AMPK family proteins such as STRADA and possibly p53/TP53. Acts as a key upstream regulator of AMPK by mediating phosphorylation and activation of AMPK catalytic subunits PRKAA1 and PRKAA2: it thereby regulates inhibition of signaling pathways that promote cell growth and proliferation when energy levels are low, glucose homeostasis in liver, activation of autophagy when cells undergo nutrient deprivation, B-cell differentiation in the germinal center in response to DNA damage. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton. Required for cortical neurons polarization by mediating phosphorylation and activation of BRSK1 and BRSK2, leading to axon initiation and specification. Involved in DNA damage response: interacts with p53/TP53 and recruited to the CDKN1A/WAF1 promoter to participate to transcription activation. Able to phosphorylate p53/TP53; the relevance of such result in vivo is however unclear and phosphorylation may be indirect and mediated by downstream STK11/LKB1 kinase NUAK1 Also acts as a mediator p53/TP53-dependent apoptosis via interaction with p53/TP53: translocates to mitochondrion during apoptosis and regulates p53/TP53-dependent apoptosis pathways.

    Subunit:
    Catalytic component of a trimeric complex composed of STK11/LKB1, STRAD (STRADA or STRADB) and CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta): the complex tethers STK11/LKB1 in the cytoplasm and stimulates its catalytic activity. Found in a ternary complex composed of SMAD4, STK11/LKB1 and STK11IP. Interacts with p53/TP53, SMAD4, STK11IP and WDR6.

    Subcellular Location:
    Nucleus. Cytoplasm. Membrane. Mitochondrion. Note=A small fraction localizes at membranes. Relocates to the cytoplasm when bound to STRAD (STRADA or STRADB) and CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta). Translocates to mitochondrion during apoptosis.

    Tissue Specificity:
    Ubiquitously expressed. Strongest expression in testis and fetal liver.

    Post-translational modifications:
    Phosphorylated by ATM at Thr-363 following ionizing radiations (IR). Phosphorylation at Ser-428 by RPS6KA1 and/or some PKA is required to inhibit cell growth. Phosphorylation at Ser-428 is also required during neuronal polarization to mediate phosphorylation of BRSK1 and BRSK2.

    DISEASE:
    Defects in STK11 are a cause of Peutz-Jeghers syndrome (PJS) [MIM:175200]. PJS is a rare hereditary disease in which there is predisposition to benign and malignant tumors of many organ systems. PJS is an autosomal dominant disorder characterized by melanocytic macules of the lips, multiple gastrointestinal hamartomatous polyps and an increased risk for various neoplasms, including gastrointestinal cancer.

    Defects in STK11 have been associated with testicular tumors (TEST) [MIM:273300]. A common solid malignancy in males. Germ cell tumors of the testis constitute 95% of all testicular neoplasms.

    Note=Defects in STK11 are associated with some sporadic cancers, especially lung cancers. Frequently mutated and inactivated in non-small cell lung cancer (NSCLC). Defects promote lung cancerigenesis process, especially lung cancer progression and metastasis. Confers lung adenocarcinoma the ability to trans-differentiate into squamous cell carcinoma. Also able to promotes lung cancer metastasis, via both cancer-cell autonomous and non-cancer-cell autonomous mechanisms.

    Similarity:
    Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. LKB1 subfamily.
    Contains 1 protein kinase domain.

    SWISS:
    Q15831

    Gene ID:
    6794

    Database links:

    Entrez Gene: 6794 Human

    Entrez Gene: 20869 Mouse

    Omim: 602216 Human

    SwissProt: Q15831 Human

    SwissProt: Q9WTK7 Mouse

    Unigene: 515005 Human



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    LKB1基因是一種抑癌基因,也是一種絲氨酸/蘇氨酸蛋白激酶.LKB1的功能主要是使細(xì)胞周期阻滯在G1期、促進(jìn)細(xì)胞凋亡和調(diào)節(jié)胚胎血管形成等.LKB1基因的胚系突變是Peutz-Jeghers綜合征的主要致病因素.在散發(fā)腫瘤中也發(fā)現(xiàn)有LKB1基因突變,其中以肺腺癌和子宮頸粘液癌突變率較高。



































    image.png

    image.png

    亚洲精品一区二区三区四区乱码 | 亚洲乱码日产精品BD在线观看| 亚洲精品无码永久在线观看 | 国产午夜亚洲精品| 国产成人精品日本亚洲专区6| 亚洲另类古典武侠| 亚洲婷婷在线视频| 亚洲字幕在线观看| 中文字幕 亚洲 有码 在线| 久久精品国产亚洲AV久 | 亚洲国产黄在线观看| 亚洲国产成人精品久久久国产成人一区二区三区综 | 久久精品国产亚洲7777| 亚洲综合色成在线播放| 久久久久亚洲精品男人的天堂| 亚洲综合区小说区激情区| 亚洲日韩乱码中文无码蜜桃臀网站 | 国产亚洲精品激情都市| 自拍偷自拍亚洲精品被多人伦好爽 | 亚洲AV成人精品网站在线播放| 亚洲av丰满熟妇在线播放| 亚洲精品人成在线观看| 91亚洲自偷手机在线观看| 亚洲成aⅴ人在线观看| 亚洲中文字幕久久精品无码2021| 亚洲一级毛片中文字幕| 亚洲天然素人无码专区| AV激情亚洲男人的天堂国语| 亚洲成AⅤ人影院在线观看| 国产成人精品亚洲精品| 亚洲国产精品无码久久一区二区 | 亚洲av永久无码精品秋霞电影秋| 婷婷亚洲综合一区二区| 亚洲人成影院在线观看| 亚洲Av综合色区无码专区桃色| 久久亚洲精精品中文字幕| 亚洲va成无码人在线观看| 亚洲日韩国产欧美一区二区三区 | 亚洲中久无码不卡永久在线观看| 亚洲色爱图小说专区| 亚洲视频小说图片|